These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22496605)

  • 81. [Protective effects of oxycodone on lipopolysaccharide-induced acute lung injury in rats].
    Yang B; Zhang WD; Xia YM; Zhang ZP; Li L; Zhang L; Wang WC; Wang ZD; Li XP
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(31):2498-501. PubMed ID: 27562050
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats.
    Yuan W; Song HY; Xiong J; Jiang WL; Kang GJ; Huang J; Xie SP
    Mol Med Rep; 2020 Aug; 22(2):1458-1466. PubMed ID: 32626979
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Acute Lung Injury in Response to Intratracheal Instillation of Lipopolysaccharide in an Animal Model of Emphysema Induced by Elastase.
    Rabelo MAE; Lucinda LMF; Reboredo MM; da Fonseca LMC; Reis FF; Fazza TF; Brega DR; de Paoli F; de Souza da Fonseca A; Pinheiro BV
    Inflammation; 2018 Feb; 41(1):174-182. PubMed ID: 28975419
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells.
    Ji Y; Wang Z; Li Z; Liu J
    Cell Physiol Biochem; 2010; 25(6):631-40. PubMed ID: 20511708
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Polydeoxyribonucleotide ameliorates lipopolysaccharide-induced acute lung injury via modulation of the MAPK/NF-κB signaling pathway in rats.
    Ko IG; Hwang JJ; Chang BS; Kim SH; Jin JJ; Hwang L; Kim CJ; Choi CW
    Int Immunopharmacol; 2020 Jun; 83():106444. PubMed ID: 32234670
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation.
    Pedrazza L; Cunha AA; Luft C; Nunes NK; Schimitz F; Gassen RB; Breda RV; Donadio MV; de Souza Wyse AT; Pitrez PMC; Rosa JL; de Oliveira JR
    J Cell Physiol; 2017 Dec; 232(12):3552-3564. PubMed ID: 28112391
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
    Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
    Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice.
    He Y; Zhao Y; Feng Y; Ren A; Zhang Y; Wang Y; Li H
    Eur J Pharmacol; 2020 Feb; 869():172893. PubMed ID: 31883915
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury.
    Liang Y; Luo J; Yang N; Wang S; Ye M; Pan G
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32091104
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.
    He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X
    PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Toll-like receptor 4 monoclonal antibody attenuates lipopolysaccharide-induced acute lung injury in mice.
    He Z; Chen X; Wang S; Zou Z
    Exp Ther Med; 2014 Sep; 8(3):871-876. PubMed ID: 25120616
    [TBL] [Abstract][Full Text] [Related]  

  • 92. KGFR promotes Na+ channel expression in a rat acute lung injury model.
    Liu B; Lü X; Qi C; Zheng S; Zhou M; Wang J; Yin W
    Afr Health Sci; 2014 Sep; 14(3):648-56. PubMed ID: 25352884
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Orally administered BZL-sRNA-20 oligonucleotide targeting TLR4 effectively ameliorates acute lung injury in mice.
    Zhao D; Qin Y; Liu J; Tang K; Lu S; Liu Z; Lin Y; Zhang C; Huang F; Chang J; Li C; Tian M; Ma Y; Li X; Zhou C; Li X; Peng X; Jin N; Jiang C
    Sci China Life Sci; 2023 Jul; 66(7):1589-1599. PubMed ID: 36808291
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cholesterol-Modified Anti-Il6 siRNA Reduces the Severity of Acute Lung Injury in Mice.
    Chernikov IV; Bachkova IK; Sen'kova AV; Meschaninova MI; Savin IA; Vlassov VV; Zenkova MA; Chernolovskaya EL
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727303
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Modeling of Chronic Lung Inflammation in Rats by Repeated Intratracheal Administration of LPS.
    Palikov VA; Palikova YA; Rudenko PA; Kazakov VA; Borozdina NA; Kravchenko IN; Pakhomova IA; Kazakova EN; Slashcheva GA; Semushina SG; Khokhlova ON; Dyachenko IA
    Bull Exp Biol Med; 2022 Oct; 173(6):790-793. PubMed ID: 36322314
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling.
    Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J
    Acta Pharm Sin B; 2022 Mar; 12(3):1198-1212. PubMed ID: 35530141
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MiR-370-3p targets TLR4 to regulate LPS-induced acute pneumonia in WI-38 cells.
    Yu X; Qian X; Sun R; Yang B; Zheng H; Jiang P; Li X
    Panminerva Med; 2022 Mar; 64(1):121-122. PubMed ID: 31663304
    [No Abstract]   [Full Text] [Related]  

  • 98. Efficacy of a novel class of RNA interference therapeutic agents.
    Hamasaki T; Suzuki H; Shirohzu H; Matsumoto T; D'Alessandro-Gabazza CN; Gil-Bernabe P; Boveda-Ruiz D; Naito M; Kobayashi T; Toda M; Mizutani T; Taguchi O; Morser J; Eguchi Y; Kuroda M; Ochiya T; Hayashi H; Gabazza EC; Ohgi T
    PLoS One; 2012; 7(8):e42655. PubMed ID: 22916145
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Lentiviral‑mediated inducible silencing of TLR4 attenuates neuropathic pain in a rat model of chronic constriction injury.
    Liu Y; Zhang Y; Pan R; Chen M; Wang X; Kong E; Yu W; Sun Y; Wu F
    Mol Med Rep; 2018 Dec; 18(6):5545-5551. PubMed ID: 30365084
    [TBL] [Abstract][Full Text] [Related]  

  • 100. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
    He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
    Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.